カテゴリ： MarketLine, イギリス, 企業調査

Hikma Pharmaceuticals PLC：戦略・SWOT・企業財務分析

◆英語タイトル：Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015324
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：53
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report
Summary

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Hikma Pharmaceuticals (Hikma or ‘the company’) is engaged in the development, manufacture and marketing of generic and in-licensed pharmaceutical products. The company primarily operates in the Middle East and North Africa (MENA), the US and Europe. It is headquartered in London, the UK and employs around 7,248 people.

Scope

- Detailed information on Hikma Pharmaceuticals PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Hikma Pharmaceuticals PLC in the form of a SWOT analysis
- An in-depth view of the business model of Hikma Pharmaceuticals PLC including a breakdown and examination of key business segments
- Intelligence on Hikma Pharmaceuticals PLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Hikma Pharmaceuticals PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Hikma Pharmaceuticals PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Hikma Pharmaceuticals PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Hikma Pharmaceuticals PLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Hikma Pharmaceuticals PLC: Company Overview
Hikma Pharmaceuticals PLC: Overview and Key Facts
Hikma Pharmaceuticals PLC: Overview
Hikma Pharmaceuticals PLC: Key Facts
Hikma Pharmaceuticals PLC: Key Employees
Hikma Pharmaceuticals PLC: Key Employee Biographies
Hikma Pharmaceuticals PLC: Major Products and Services
Hikma Pharmaceuticals PLC: Company History
Hikma Pharmaceuticals PLC: Management Statement
Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Hikma Pharmaceuticals PLC: Key Competitors
Hikma Pharmaceuticals PLC: Company Analysis
Hikma Pharmaceuticals PLC: Business Description
Hikma Pharmaceuticals PLC: SWOT Analysis
Hikma Pharmaceuticals PLC: SWOT Overview
Hikma Pharmaceuticals PLC: Strengths
Hikma Pharmaceuticals PLC: Weaknesses
Hikma Pharmaceuticals PLC: Opportunities
Hikma Pharmaceuticals PLC: Threats
Hikma Pharmaceuticals PLC: Corporate Financial Deals Activity
Hikma Pharmaceuticals PLC: Financial Deals Overview
Hikma Pharmaceuticals PLC: Targets and Partners
Hikma Pharmaceuticals PLC: Top Deals 2013 – 2017YTD*
Hikma Pharmaceuticals PLC: Advisors
Hikma Pharmaceuticals PLC: Top Legal Advisors
Hikma Pharmaceuticals PLC: Top Financial Advisors
Hikma Pharmaceuticals PLC: Mergers and Acquisitions
Hikma Pharmaceuticals PLC: Partnership
Hikma Pharmaceuticals PLC: Divestments
Hikma Pharmaceuticals PLC: Recent Developments
Hikma Pharmaceuticals PLC: News and Events Summary
Hikma Pharmaceuticals PLC: Business Expansion
Hikma Pharmaceuticals PLC: Corporate Governance
Hikma Pharmaceuticals PLC: Financial Deals
Hikma Pharmaceuticals PLC: Financial Performance
Hikma Pharmaceuticals PLC: Regulatory and Legal Events
Hikma Pharmaceuticals PLC: Research & Development
Hikma Pharmaceuticals PLC: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Hikma Pharmaceuticals PLC: Key Facts
Table 2: Hikma Pharmaceuticals PLC: Key Employees
Table 3: Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Table 4: Hikma Pharmaceuticals PLC: Key Competitors
Table 5: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Hikma Pharmaceuticals PLC: M&A Average Deal Size - Value (US$m)
Table 7: Hikma Pharmaceuticals PLC: Targets and Partners
Table 8: Hikma Pharmaceuticals PLC: Top Deals 2013 - 2017YTD*
Table 9: Hikma Pharmaceuticals PLC: Legal Advisor Ranking by Value (US$m)
Table 10: Hikma Pharmaceuticals PLC: Financial Advisor Ranking by Value (US$m)
Table 11: Hikma Pharmaceuticals PLC: M&A Volume and Value Trend (2013 - YTD*2017)
Table 12: Hikma Pharmaceuticals PLC: M&A Activity by Geography (2013 - YTD*2017)
Table 13: Hikma Pharmaceuticals PLC: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 14: Hikma Pharmaceuticals PLC: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 15: Hikma Pharmaceuticals PLC: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 16: Hikma Pharmaceuticals PLC: News and Events Summary
Table 17: Hikma Pharmaceuticals PLC: Business Expansion
Table 18: Hikma Pharmaceuticals PLC: Corporate Governance
Table 19: Hikma Pharmaceuticals PLC: Financial Deals
Table 20: Hikma Pharmaceuticals PLC: Financial Performance
Table 21: Hikma Pharmaceuticals PLC: Regulatory and Legal Events
Table 22: Hikma Pharmaceuticals PLC: Research & Development
Table 23: Hikma Pharmaceuticals PLC: Strategy and Operations

★海外企業調査レポート[Hikma Pharmaceuticals PLC：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • PDL BioPharma Inc (PDLI)：企業の財務・戦略的SWOT分析
    PDL BioPharma Inc (PDLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Covea Mutual Insurance Group Company：企業の戦略・SWOT・財務情報
    Covea Mutual Insurance Group Company - Strategy, SWOT and Corporate Finance Report Summary Covea Mutual Insurance Group Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Chubu Electric Power Company, Incorporated：企業の戦略・SWOT・財務分析
    Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Midatech Pharma Plc (MTPH)：製薬・医療：M&Aディール及び事業提携情報
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • Columbia Power Corporation：企業の戦略的SWOT分析
    Columbia Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • lululemon athletica inc.：企業の戦略・SWOT・財務情報
    lululemon athletica inc. - Strategy, SWOT and Corporate Finance Report Summary lululemon athletica inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Dyadic International Inc (DYAI)-製薬・医療分野：企業M&A・提携分析
    Summary Dyadic International Inc (Dyadic) is a biotechnology company that discovers, develops, manufactures and commercializes protein-based drugs. The company utilizes its patented and proprietary technology Myceliopthora thermophila (C1) expression system, to conduct research and produce industria …
  • Pudumjee Paper Products Limited：企業の戦略・SWOT・財務情報
    Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report Summary Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • SK Telecom Co., Ltd.：企業の戦略・SWOT・財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • O’Reilly Automotive, Inc.：企業の戦略・SWOT・財務情報
    O'Reilly Automotive, Inc. - Strategy, SWOT and Corporate Finance Report Summary O'Reilly Automotive, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Southern Maryland Electric Cooperative Inc：企業の戦略的SWOT分析
    Southern Maryland Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Valneva SE (VLA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Valneva SE (Valneva) is a biotech company that develops lifesaving vaccines. The company’s products include IXIARO, a vaccine indicated for the prevention of Japanese encephalitis; and Dukoral, a vaccine indicated for the prevention of cholera and diarrhea; clostridium difficile, lyme, chiku …
  • Polymetal International Plc：戦略・SWOT・企業財務分析
    Polymetal International Plc - Strategy, SWOT and Corporate Finance Report Summary Polymetal International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Reno de Medici S.p.A.：企業の戦略・SWOT・財務情報
    Reno de Medici S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Reno de Medici S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Catholic Health Initiatives：企業の戦略・SWOT・財務情報
    Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report Summary Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Big River Gold Ltd (CAS)：企業の財務・戦略的SWOT分析
    Summary Big River Gold Ltd (Big River Gold) is formerly known as Crusader resources Ltd is a mineral exploration company. The company explores for gold, iron ore and tin deposits. Its projects portfolio includes Borborema Gold project, Posse Iron Ore project, Tarantula Tungsten project, Juruena Gold …
  • St.George Bank：企業の戦略的SWOT分析
    St.George Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Alder Biopharmaceuticals Inc (ALDR)：製薬・医療：M&Aディール及び事業提携情報
    Summary Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection sy …
  • Ebara Corp (6361)：企業の財務・戦略的SWOT分析
    Ebara Corp (6361) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • University of Birmingham-製薬・医療分野：企業M&A・提携分析
    Summary University of Birmingham is an academic research university that offers educational services. The university provides undergraduate, postgraduate, postgraduate research, and distance learning programs. It offers educational courses in various fields including accounting, astronomy, computer …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆